147 related articles for article (PubMed ID: 9884918)
21. Drop-out reasons and complications in self-injection therapy with a triple vasoactive drug mixture in sexual erectile dysfunction.
Casabé A; Bechara A; Cheliz G; Romano S; Rey H; Fredotovich N
Int J Impot Res; 1998 Mar; 10(1):5-9. PubMed ID: 9542684
[TBL] [Abstract][Full Text] [Related]
22. Peyronie's-like plaque after penile injection of prostaglandin E1.
Chen J; Godschalk M; Katz PG; Mulligan T
J Urol; 1994 Sep; 152(3):961-2. PubMed ID: 8051767
[TBL] [Abstract][Full Text] [Related]
23. Intracavernous injections of prostaglandin E1 for erectile dysfunction: patient satisfaction and quality of sex life on long-term treatment.
Alexandre B; Lemaire A; Desvaux P; Amar E
J Sex Med; 2007 Mar; 4(2):426-31. PubMed ID: 17367438
[TBL] [Abstract][Full Text] [Related]
24. A double-blind, placebo-controlled evaluation of the erectile response to transurethral alprostadil.
Hellstrom WJ; Bennett AH; Gesundheit N; Kaiser FE; Lue TF; Padma-Nathan H; Peterson CA; Tam PY; Todd LK; Varady JC; Place VA
Urology; 1996 Dec; 48(6):851-6. PubMed ID: 8973666
[TBL] [Abstract][Full Text] [Related]
25. Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.
Chochina L; Naudet F; Chéhensse C; Manunta A; Damphousse M; Bonan I; Giuliano F
Sex Med Rev; 2016 Jul; 4(3):257-269. PubMed ID: 27871959
[TBL] [Abstract][Full Text] [Related]
26. Intracavernous prostaglandin E1 in erectile dysfunction.
Linet OI; Neff LL
Clin Investig; 1994 Jan; 72(2):139-49. PubMed ID: 8186662
[TBL] [Abstract][Full Text] [Related]
27. Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.
He L; Wen J; Jiang X; Chen H; Tang Y
Andrologia; 2011 Jun; 43(3):208-12. PubMed ID: 21486416
[TBL] [Abstract][Full Text] [Related]
28. Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study. The Sildenafil Multicenter Study Group.
Giuliano F; Montorsi F; Mirone V; Rossi D; Sweeney M
J Urol; 2000 Sep; 164(3 Pt 1):708-11. PubMed ID: 10953130
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group.
Williams G; Abbou CC; Amar ET; Desvaux P; Flam TA; Lycklama à Nijeholt GA; Lynch SF; Morgan RJ; Müller SC; Porst H; Pryor JP; Ryan P; Witzsch UK; Hall MM; Place VA; Spivack AP; Gesundheit N
Br J Urol; 1998 Jun; 81(6):889-94. PubMed ID: 9666777
[TBL] [Abstract][Full Text] [Related]
30. Prospective comparative study with intracavernous sodium nitroprusside and prostaglandin E1 in patients with erectile dysfunction.
Martínez-Piñeiro L; Cortés R; Cuervo E; López-Tello J; Cisneros J; Martínez-Piñeiro JA
Eur Urol; 1998 Oct; 34(4):350-4. PubMed ID: 9748684
[TBL] [Abstract][Full Text] [Related]
31. [The opinion of patients treated with intracavernous injections: the EASY survey].
Desvaux P; Alexandre B
Presse Med; 2005 Jul; 34(13 Suppl):10-2. PubMed ID: 16158022
[TBL] [Abstract][Full Text] [Related]
32. Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction.
Buvat J; Costa P; Morlier D; Lecocq B; Stegmann B; Albrecht D
J Urol; 1998 Jan; 159(1):116-9. PubMed ID: 9400450
[TBL] [Abstract][Full Text] [Related]
33. Cavernous auto-injection therapy with prostaglandin E1.
Nisén H
Ann Chir Gynaecol Suppl; 1993; 206():69-73. PubMed ID: 8291874
[TBL] [Abstract][Full Text] [Related]
34. Office treatment: intracavernous injections of prostaglandin E1 (PG E1) and improvement of spontaneous erections.
Beretta G; Marzotto M; Zanollo A; Re B
Acta Eur Fertil; 1991; 22(4):221-3. PubMed ID: 1844326
[TBL] [Abstract][Full Text] [Related]
35. [The intracavernous injection of Edex (prostaglandin E1) in the treatment of erectile impotence in persons in older age groups].
Gorilovskiĭ LM
Urol Nefrol (Mosk); 1996; (6):31-3. PubMed ID: 9036606
[TBL] [Abstract][Full Text] [Related]
36. Long-term, multicenter study of the safety and efficacy of topical alprostadil cream in male patients with erectile dysfunction.
Rooney M; Pfister W; Mahoney M; Nelson M; Yeager J; Steidle C
J Sex Med; 2009 Feb; 6(2):520-34. PubMed ID: 19138370
[TBL] [Abstract][Full Text] [Related]
37. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group.
Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184
[TBL] [Abstract][Full Text] [Related]
38. Our experience with pharmacological erection treatment of erectile dysfunction.
Hattat H; Ozkara H; Akkus E; Alici B
J Androl; 1994; 15 Suppl():47S-49S. PubMed ID: 7721677
[TBL] [Abstract][Full Text] [Related]
39. [Intracavernous pharmacotherapy for treatment and evaluation of impotence].
Vardi Y; Lidgi S; Moskovitz B; Levin RD
Harefuah; 1991 Oct; 121(7-8):223-5. PubMed ID: 1783307
[TBL] [Abstract][Full Text] [Related]
40. [Transurethral alprostadil administration with MUSE ("Medicated Urethral System for Erection"). Current overview and personal experiences].
Porst H
Urologe A; 1998 Jul; 37(4):410-6. PubMed ID: 9738294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
